A researcher prepares a sample inside a laboratory at BeiGene Ltd’s research and development centre in Beijing on May 24, 2018. The company made its Hong Kong trading debut in August 2018. Photo: Bloomberg
A researcher prepares a sample inside a laboratory at BeiGene Ltd’s research and development centre in Beijing on May 24, 2018. The company made its Hong Kong trading debut in August 2018. Photo: Bloomberg
Bonnie Y. Chan
Opinion

Opinion

The View by Bonnie Y. Chan

How Hong Kong can cement its position as a biotech listing hub

  • To maintain its growth and quality, Hong Kong’s biotech sector needs more bankers, analysts and lawyers with international expertise
  • Given the short history of the sector and the technical nature of biotech finance skills, the pool of home-grown talent is small, though growing

A researcher prepares a sample inside a laboratory at BeiGene Ltd’s research and development centre in Beijing on May 24, 2018. The company made its Hong Kong trading debut in August 2018. Photo: Bloomberg
A researcher prepares a sample inside a laboratory at BeiGene Ltd’s research and development centre in Beijing on May 24, 2018. The company made its Hong Kong trading debut in August 2018. Photo: Bloomberg
READ FULL ARTICLE